News

Bajaj Healthcare Limited will hold a board meeting on Saturday, October 17, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The company also announced that the trading window for securities will be closed for insiders and designated persons from October 1, 2026, until 48 hours after the financial results are declared.

Bajaj Healthcare Limited will close its trading window for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half year ended September 30, 2026, in accordance with SEBI regulations and company policy.

Bajaj Healthcare Limited has set September 14, 2026, as the record date to determine eligibility for a final dividend of Rs 1.50 per equity share, representing 30%, for the financial year 2025-26, pending declaration and approval by shareholders at the company’s annual general meeting.

Bajaj Healthcare Limited announced the allotment of 2,500 equity shares following the exercise of employee stock options under the Bajaj Healthcare Limited Employee Stock Option Scheme 2024, according to a regulatory filing on August 21, 2026. The company realized Rs 12,500 from the exercise of the options, with the shares ranking pari-passu with existing equity, increasing the issued, subscribed, and paid-up equity share capital to Rs 16,83,25,805 divided into 3,36,65,161 equity shares.

Bajaj Healthcare announced that India Ratings and Research (Ind-Ra) has upgraded the credit ratings assigned to the bank loan facilities of Bajaj Healthcare Limited. The Company`s long-term bank loan facilities have been upgraded to `IND A` from `IND A-` with a Stable Outlook, and the short-term bank loan facilities have been upgraded to `IND A1` from `IND A2+`.